- Investing Ideas
- Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
47
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
47 companies
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$518.66
7D
-0.3%
1Y
69.3%
Axsome Therapeutics
Market Cap: US$11.5b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$223.70
7D
20.9%
1Y
99.4%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$107.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$456.80
7D
-2.6%
1Y
35.3%
ALTEOGEN
Market Cap: ₩20.0t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩373,000.00
7D
-1.6%
1Y
4.6%
Insmed
Market Cap: US$28.8b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$140.01
7D
3.0%
1Y
92.9%
Akeso
Market Cap: HK$117.7b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$127.80
7D
-6.3%
1Y
47.4%
Ionis Pharmaceuticals
Market Cap: US$12.4b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$75.45
7D
4.5%
1Y
124.3%
Alnylam Pharmaceuticals
Market Cap: US$39.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$297.93
7D
-3.4%
1Y
8.9%
Ascendis Pharma
Market Cap: US$13.6b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$228.71
7D
0.9%
1Y
n/a
Neurocrine Biosciences
Market Cap: US$13.3b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$134.07
7D
4.7%
1Y
22.2%
BeOne Medicines
Market Cap: US$32.7b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$297.14
7D
-0.6%
1Y
16.9%
argenx
Market Cap: €42.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€684.40
7D
1.1%
1Y
18.2%
BridgeBio Pharma
Market Cap: US$13.4b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$68.99
7D
-7.4%
1Y
80.5%
Torrent Pharmaceuticals
Market Cap: ₹1.4t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹4,275.95
7D
2.2%
1Y
30.8%
AstraZeneca
Market Cap: UK£209.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£135.12
7D
-2.8%
1Y
26.3%
Galderma Group
Market Cap: CHF 38.5b
Operates as a dermatology company worldwide.
GALD
CHF 164.15
7D
0.4%
1Y
65.6%
Chugai Pharmaceutical
Market Cap: JP¥13.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,245.00
7D
3.8%
1Y
-4.4%
AbbVie
Market Cap: US$365.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$208.16
7D
5.5%
1Y
6.2%
Sartorius Stedim Biotech
Market Cap: €15.1b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€155.50
7D
-2.6%
1Y
-27.1%
Innovent Biologics
Market Cap: HK$160.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$92.00
7D
11.4%
1Y
69.4%
Jazz Pharmaceuticals
Market Cap: US$12.5b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$208.06
7D
3.4%
1Y
76.0%
Eli Lilly
Market Cap: US$859.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$967.93
7D
11.5%
1Y
17.8%
Swedish Orphan Biovitrum
Market Cap: SEK 149.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 431.80
7D
8.3%
1Y
45.6%
Natera
Market Cap: US$29.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$211.56
7D
3.5%
1Y
34.4%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.2b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€49.88
7D
0.2%
1Y
-6.2%
Viatris
Market Cap: US$17.5b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$15.20
7D
2.6%
1Y
76.9%
Royalty Pharma
Market Cap: US$29.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$50.20
7D
1.1%
1Y
52.1%
Sandoz Group
Market Cap: CHF 27.2b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 62.86
7D
0.03%
1Y
70.8%
Takeda Pharmaceutical
Market Cap: JP¥8.3t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,239.00
7D
-0.9%
1Y
18.6%
Novartis
Market Cap: CHF 217.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 113.84
7D
-0.2%
1Y
22.5%
Orion Oyj
Market Cap: €9.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€69.15
7D
2.1%
1Y
22.9%
Merck
Market Cap: US$277.0b
Operates as a healthcare company worldwide.
MRK
US$113.11
7D
2.6%
1Y
36.5%
Daiichi Sankyo Company
Market Cap: JP¥4.8t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,616.50
7D
-1.3%
1Y
-29.3%
Sino Biopharmaceutical
Market Cap: HK$97.9b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.44
7D
-0.7%
1Y
37.7%
Elanco Animal Health
Market Cap: US$11.2b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.51
7D
1.9%
1Y
133.3%
Genmab
Market Cap: DKK 104.8b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,707.50
7D
0.03%
1Y
19.4%